Heart failure hospitalizations decrease when doctors and pharmacists collaborate to ensure patients take their medicines
Thinking "outside the medicine cabinet" is paying off
in Australia, where a doctor-pharmacist partnership is reducing hospitalizations
for heart failure - one of the most expensive conditions to treat - researchers
report in Circulation: Heart Failure.
In the American Heart Association journal, researchers
describe a collaborative model for ensuring heart failure patients take their
medicines properly. The rate of hospitalization was cut by 45 percent in the first
year of being part of a collaborative medicines review service.
"This is the first study to show these benefits in real-world
practice rather than in a trial setting," said Elizabeth E. Roughead, Ph.D., lead
author of the study and a pharmacist and associate professor in the School of
Pharmacy and Medical Sciences at the University of South Australia in Adelaide.
"If you have heart failure, getting a home visit with your pharmacist and then
having a follow-up visit with your doctor about your medicines can keep you out
of the hospital."
Researchers followed 273 heart failure patients over
age 65 who underwent collaborative medicine review and compared them to 5,444
controls who didn't have their medicines reviewed. The participants were Australian
veterans, who have extremely detailed medical records. All participants took one
of three types of beta-blocker drugs. Before these drugs are used, Australian
physicians must sign paperwork confirming a heart failure diagnosis.
Those in the test group were slightly sicker than controls,
and had more co-morbidities (eight other conditions vs. seven for the controls).
Compared to controls, the group undergoing medicine review also had more prescriptions,
more changes in medication prior to their home review, prescriptions from a higher
number of caregivers and more hospitalizations.
After adjusting for a range of possible confounders,
the researchers found that only 5.5 percent of the patients in the collaborative
review group were hospitalized within a year, compared to 12 percent of the control
group.
The collaborative approach features house calls with
a twist: Pharmacists go to patients' homes and ask them to bring out all their
prescription and non-prescription medications. The pharmacists are trained to
notice signs of possible medication misuse, including under-dosing, overdosing
and hoarding unneeded medicines from old prescriptions - a habit that increases
the chance of accidentally taking the wrong medicine.
The pharmacists also look for over-the-counter medications
and vitamins that could interact with the patients' prescription drugs. The average
age of patients in both groups was 81.6 years, Roughead said.
Under the system used in Australia since 2001, a patient's
general practitioner provides a referral to a pharmacist with the special collaborative
training. The pharmacist conducts an interview, preferably in the patient's home,
and reports findings from the review to the general practitioner. The report notes
any known or potential problems the patient may have managing their medicines.
The doctor then follows up with the patient if necessary. That follow-up could
include showing the patient how, why and when to take their medicines or discussing
proper ways to store the drugs as well as describing possible interactions between
prescriptions, non-prescription medicines or vitamins found in the home by the
pharmacist.
"Poor use of medicines can increase costs enormously,"
Roughead said. "This study indicates that investing in improvements in medication
management can result in more cost-effective health care."
Co-authors include John D. Barratt, B. Pharm., B. App.
Sc.; Emmae Ramsay, B.Sc.; Nicole Pratt, B.Sc.; Philip Ryan, M.B.B.S.; Robert Peck,
B. Pharm.; Graeme Killer, M.B.B.S. and Andrew L. Gilbert, Ph.D.
The Australian Government Department of Veterans' Affairs
funded the research.
|